CX 2024: Focus on controversy-filled venous treatmentshonorapamplin2024-04-19T12:19:03+01:00
CX 2023: Reaching Venous Consensus with a World-Class Faculty
[email protected]2023-03-21T15:55:58+00:00“I think the Charing Cross programme has worked very hard to make a comprehensive and up-to-date consensus on what we have available to us now, what we know now and where we are going.”
This week we sat down with Executive Board member and vascular surgeon Erin Murphy (Charlotte, United States) to talk […]
CX 2023: Reaching Venous and Lymphatic Consensus with a World-Class Faculty
[email protected]2022-12-15T12:26:15+00:00CX 2023 is seeking to reach venous and lymphatic consensus on topics related to the superficial, deep and pelvic veins as well as venous ulcers and lymphatics. Reaching consensus this year will round out our three-year cycle of controversies, challenges and consensus. Topics will be addressed by the world-class CX faculty alongside […]
CX 2022: A conversation with Dr Erin Murphy
Adam Pearce2022-08-09T12:28:19+01:00
CX 2022 will highlight Venous and Lymphatic Challenges, focusing on appropriate care conundrums to venous challenges in relation to the “hurting leg”. Challenges related to the superficial, deep and pelvic veins, as well as venous wounds, will be addressed by global thought leaders alongside audience participation, polling and discussion. Be a part […]
CX 2021: Venous and Lymphatic Highlights
Anthony Strzalek2021-04-29T20:09:24+01:00CX 2021 has finished but that does not mean you have missed your opportunity to view all the high-quality content that was on display. All our sessions, from both Livestream 1 and Livestream 2, are available on-demand on our dedicated CX 2021 channel.
To get access to the entire content from […]
World-class Faculty lined up to tackle Superficial Venous & Lymphatic Controversies
Anthony Strzalek2021-03-05T15:24:48+00:00Lowell Kabnick (USA) talks about what he is looking forward to in the upcoming Venous & Lymphatic Controversies (Superficial) session at CX 2021. He also discusses his own presentation, Is there evidence to justify an aggressive strategy for the ablation of incompetent perforators?. This controversial topic is “important to the […]
CX 2020 LIVE: Deep venous session to examine stent durability and design
Anthony Strzalek2020-06-11T13:20:21+01:00Armando Mansilha (Porto, Portugal), who is also a member of the CX Venous Executive Board, welcomes you to the Deep Venous Disease Consensus session at CX 2020 LIVE. Deep venous disease is a “significant medical problem for patients” and also a “substantial burden for our healthcare systems”, notes Mansilha.
In […]
CX 2020 LIVE to flag latest guidelines and stent durability in superficial and deep venous programmes
Anthony Strzalek2020-05-20T12:57:01+01:00Manj Gohel (Cambridge, UK), who is also a member of the CX Venous Executive Board, welcomes you to CX 2020 LIVE, which will include some of the major highlights from the deep and superficial venous programmes.
A number of recently released “important guidelines” in the superficial venous space will be presented […]
With CoveredSeal, Valiant Navion™ offers physicians the “best of both worlds” for TEVAR procedures
Anthony Strzalek2019-09-06T16:05:44+01:00Paul Hayes (Cambridge, UK), Frank Arko (Charlotte, USA) and Fabio Verzini (Turin, Italy) discuss the Valiant Navion™ (Medtronic) live thoracic endovascular aortic repair (TEVAR) case at Charing Cross 2019, which demonstrated the use of the new CoveredSeal proximal configuration.
Hayes talks about the accuracy of the device’s deployment around the thoracic […]
CX 2017: Venous Consensus highlights
cxsymposium2019-09-09T10:16:00+01:00The CX 2017 Venous Consensus Update Programme will focus on PATHWAYS OF CARE – whether to intervene, when and at what threshold, method and follow-up, providing delegates with discussions on diagnosis and treatment options for the whole spectrum of venous disease.
Roger Greenhalgh (Chairman, CX Programme Organising Board) discusses with Stephen Black (member, CX Programme Organising […]